Title |
Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis – focus on subcutaneous tocilizumab
|
---|---|
Published in |
Drug Design, Development and Therapy, July 2014
|
DOI | 10.2147/dddt.s52099 |
Pubmed ID | |
Authors |
Yasuharu Nakashima, Masakazu Kondo, Hisaaki Miyahara, Yukihide Iwamoto |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 26% |
Student > Master | 9 | 23% |
Researcher | 6 | 15% |
Student > Doctoral Student | 3 | 8% |
Student > Bachelor | 2 | 5% |
Other | 4 | 10% |
Unknown | 5 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 23% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 21% |
Agricultural and Biological Sciences | 4 | 10% |
Nursing and Health Professions | 3 | 8% |
Social Sciences | 2 | 5% |
Other | 6 | 15% |
Unknown | 7 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#7,862,564
of 25,604,262 outputs
Outputs from Drug Design, Development and Therapy
#529
of 2,271 outputs
Outputs of similar age
#70,583
of 242,703 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 38 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,703 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.